Breaking News
FONT-SIZE Plus   Neg
Share SHARE

Dechra Pharma 6-month Underlying EPS Up - Quick Facts

Dechra Pharmaceuticals Plc's (DPH.L) six-month pre-tax profit decreased to 8.9 million pounds from 9.0 million pounds in the prior-year period. On a per share basis, half-yearly earnings improved to 10.06 pence from 10.05 pence a year ago.

Underlying pre-tax profit was 14.3 million pounds compared with 13.9 million pounds achieved in 2010. At constant currency and excluding foreign currency gains and losses, underlying pre-tax profit was £15.1 million, up 11.3% versus 2010. Underlying earnings per share were 15.82 pence, higher than last year's 15.51 pence.

Revenue for the six months ended December 31, 2011 totaled 209.5 million pounds, up 9.0% from 192.2 million pounds in the previous year.

The board also declared an interim dividend of 4.1 pence per share, an increase of 10.8%, payable on 10 April 2012 to Shareholders on the Register of Members at close of business on 9 March 2012. The ordinary shares would become ex dividend on 7 March 2012.

Click here to receive FREE breaking news email alerts for Dechra Pharm PLC and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
After trending higher over the past several sessions, stocks showed a lack of direction throughout the trading day on Friday before closing roughly flat. A muted reaction to a highly anticipated speech by Federal Reserve Chair Janet Yellen contributed to the lackluster performance. Republican Scott Brown has significantly narrowed the gap in the race against incumbent New Hampshire Sen. Jeanne Shaheen, D-N.H., according to the results of a new WMUR Granite State Poll. On the heels of the violent clashes between local police and protestors in Ferguson, Missouri, Sen. Claire McCaskill, D-Mo., announced that she will hold a Senate hearing in September to examine the militarization of local police departments.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.